Europe — EMA
Neo-Endusix (Tenoxicam)
GNH USA supplies Neo-Endusix (Tenoxicam), an NSAID for rheumatoid arthritis, osteoarthritis and post‑operative pain. Request a quote for worldwide supply.
Request sourcing
What is Tenoxicam?
Tenoxicam, the active ingredient in Neo-Endusix, is a oxicam presented as a injection for intramuscular, intravenous use. It treats rheumatoid arthritis, osteoarthritis, acute musculoskeletal pain and post‑operative pain in adult patients.
GNH USA supplies Neo-Endusix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Tenoxicam used for?
Tenoxicam is an oxicam NSAID used to manage inflammatory and painful conditions affecting the musculoskeletal system.
Rheumatoid arthritis: reduces joint inflammation and pain. Osteoarthritis: alleviates chronic joint discomfort and swelling. Acute musculoskeletal pain: provides rapid relief of pain and inflammation. Post‑operative pain: controls postoperative inflammatory pain.
What are the side effects of Tenoxicam?
Tenoxicam may cause a range of adverse reactions, from mild to severe.
Common Side Effects: - Gastrointestinal irritation or dyspepsia. - Nausea. - Headache. - Injection‑site pain or mild erythema.
Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Severe hepatic injury. - Anaphylactic reaction. - Blood dyscrasias such as agranulocytosis. - Cardiovascular thrombotic events.
What precautions apply to Tenoxicam?
Tenoxicam should be used with caution in patients with certain conditions.
Assess renal function: avoid or adjust use in severe renal impairment. Monitor hepatic enzymes: contraindicated in severe liver disease. Evaluate cardiovascular risk: use cautiously in patients with heart disease. Review concomitant NSAIDs or anticoagulants: increased bleeding risk. Store at ambient temperature: keep in original container, protect from light and moisture.
What does Tenoxicam interact with?
Tenoxicam can interact with several medicines, requiring attention.
Major Interactions (Avoid): - Warfarin: heightened bleeding risk. - Lithium: increased serum lithium concentrations. - Methotrexate: enhanced toxicity.
Moderate Interactions (Monitor Closely): - ACE inhibitors: possible decline in renal function. - Diuretics: risk of reduced renal clearance. - SSRIs or SNRIs: increased bleeding tendency.



